196 related articles for article (PubMed ID: 33223557)
1. A comparison of SARS-CoV-2 antibody assays evaluated in Auckland, New Zealand.
Fox-Lewis S; Whitcombe A; McGregor R; Carlton L; Hwang Y; Austin P; Aspin L; Raill B; Webb R; Taylor S; Morpeth S; Roberts S; Moreland NJ; McAuliffe G
N Z Med J; 2020 Nov; 133(1525):127-131. PubMed ID: 33223557
[No Abstract] [Full Text] [Related]
2. Correlation of SARS-CoV-2 Neutralizing Antibodies to an Automated Chemiluminescent Serological Immunoassay.
Grenache DG; Ye C; Bradfute SB
J Appl Lab Med; 2021 Mar; 6(2):491-495. PubMed ID: 33098417
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of four rapid SARS-CoV-2 antigen detection tests using universal transport medium.
Weitzel T; Legarraga P; Iruretagoyena M; Pizarro G; Vollrath V; Araos R; Munita JM; Porte L
Travel Med Infect Dis; 2021; 39():101942. PubMed ID: 33278609
[No Abstract] [Full Text] [Related]
4. Analytical and Clinical Analysis of Two Automated Anti-SARS-CoV-2 Immunoassays in Pre-Pandemic and Pandemic Patient Populations.
Yang J; Pederson EC; Hamilton C; Neibauer T; Robyak K; McGhee P; Speicher T; Zhu Y
J Appl Lab Med; 2021 Mar; 6(2):441-450. PubMed ID: 33152084
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a SARS-CoV-2 Surrogate Virus Neutralization Test for Detection of Antibody in Human, Canine, Cat, and Hamster Sera.
Perera RAPM; Ko R; Tsang OTY; Hui DSC; Kwan MYM; Brackman CJ; To EMW; Yen HL; Leung K; Cheng SMS; Chan KH; Chan KCK; Li KC; Saif L; Barrs VR; Wu JT; Sit THC; Poon LLM; Peiris M
J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33139421
[TBL] [Abstract][Full Text] [Related]
6. Clinical performance of the Advia Centaur anti-SARS-CoV-2 chemiluminescent immunoassay related to antibody kinetics.
Ocmant A; Roisin S; De Meuter R; Brauner J
J Med Virol; 2021 May; 93(5):2583-2584. PubMed ID: 33448403
[No Abstract] [Full Text] [Related]
7. SARS-CoV-2-specific IgM screening has low sensitivity for identifying potentially infectious travellers.
Hasan T; Lim HL; Hueston L; Dwyer DE; O'Sullivan M
Pathology; 2021 Dec; 53(7):917-919. PubMed ID: 34635322
[No Abstract] [Full Text] [Related]
8. SARS-CoV-2 infection serology validation of different methods: Usefulness of IgA in the early phase of infection.
Pieri M; Ciotti M; Carlozzi N; Frassanito ML; Meloni A; Cistera A; Turchetti G; Niscola S; Labate G; Calugi G; Bernardini S
Clin Chim Acta; 2020 Dec; 511():28-32. PubMed ID: 33002475
[TBL] [Abstract][Full Text] [Related]
9. Usefulness and limitations of implementing rapid tests for the diagnosis of COVID-19 in Latin America.
García-Díaz G; Montalvo-Varela E; Cano-Pérez E; da Silva Francisco Junior R; Rodriguez-Morales A
Infez Med; 2020 Dec; 28(4):642-644. PubMed ID: 33257642
[TBL] [Abstract][Full Text] [Related]
10. Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand.
Chaimayo C; Kaewnaphan B; Tanlieng N; Athipanyasilp N; Sirijatuphat R; Chayakulkeeree M; Angkasekwinai N; Sutthent R; Puangpunngam N; Tharmviboonsri T; Pongraweewan O; Chuthapisith S; Sirivatanauksorn Y; Kantakamalakul W; Horthongkham N
Virol J; 2020 Nov; 17(1):177. PubMed ID: 33187528
[TBL] [Abstract][Full Text] [Related]
11. Are Seroprevalence Estimates for Severe Acute Respiratory Syndrome Coronavirus 2 Biased?
Takahashi S; Greenhouse B; Rodríguez-Barraquer I
J Infect Dis; 2020 Nov; 222(11):1772-1775. PubMed ID: 32856712
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Panbio COVID-19 Rapid Antigen Detection Test Device for the Screening of Patients with COVID-19.
Fenollar F; Bouam A; Ballouche M; Fuster L; Prudent E; Colson P; Tissot-Dupont H; Million M; Drancourt M; Raoult D; Fournier PE
J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33139420
[No Abstract] [Full Text] [Related]
13. Comparison of the clinical performance and usefulness of five SARS-CoV-2 antibody tests.
Wakita M; Idei M; Saito K; Horiuchi Y; Yamatani K; Ishikawa S; Yamamoto T; Igawa G; Hinata M; Kadota K; Kurosawa T; Takahashi S; Saito T; Misawa S; Akazawa C; Naito T; Miida T; Takahashi K; Ai T; Tabe Y
PLoS One; 2021; 16(2):e0246536. PubMed ID: 33556086
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of six anti-SARS-CoV-2 antibody test kits and practical approaches to optimize the diagnostic performance.
Ko JH; Joo EJ; Baek JY; Huh K; Cho SY; Kang CI; Chung DR; Kim YJ; Kang ES; Peck KR
J Microbiol Immunol Infect; 2021 Oct; 54(5):983-986. PubMed ID: 33836943
[TBL] [Abstract][Full Text] [Related]
15. Analytical sensitivity and clinical sensitivity of the three rapid antigen detection kits for detection of SARS-CoV-2 virus.
Mak GC; Lau SS; Wong KK; Chow NL; Lau CS; Lam ET; Chan RC; Tsang DN
J Clin Virol; 2020 Dec; 133():104684. PubMed ID: 33176236
[TBL] [Abstract][Full Text] [Related]
16. Coronavirus disease 2019 antibody testing in pregnancy.
Zullo F; Di Mascio D; Saccone G
Am J Obstet Gynecol MFM; 2020 Aug; 2(3):100142. PubMed ID: 32427172
[No Abstract] [Full Text] [Related]
17. Comparative analysis of three laboratory based serological assays for SARS-CoV-2 in an Australian cohort.
Davidson N; Evans J; Giammichele D; Powell H; Hobson P; Teis B; Glover H; Guppy-Coles KB; Robson J
Pathology; 2020 Dec; 52(7):764-769. PubMed ID: 33070955
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the newly developed BioFire COVID-19 test for SARS-CoV-2 molecular detection.
Liotti FM; Menchinelli G; Marchetti S; Morandotti GA; Sanguinetti M; Posteraro B; Cattani P
Clin Microbiol Infect; 2020 Dec; 26(12):1699-1700. PubMed ID: 32735938
[No Abstract] [Full Text] [Related]
19. Rapid coronavirus tests: a guide for the perplexed.
Guglielmi G
Nature; 2021 Feb; 590(7845):202-205. PubMed ID: 33564189
[No Abstract] [Full Text] [Related]
20. Greater public health impact of COVID-19 antigen detection tests.
Kowada A
BMC Med; 2021 Mar; 19(1):82. PubMed ID: 33757504
[No Abstract] [Full Text] [Related]
[Next] [New Search]
